These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8318606)

  • 21. Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo.
    Okamura Y; Maekawa I; Teramura Y; Maruyama H; Handa M; Ikeda Y; Takeoka S
    Bioconjug Chem; 2005; 16(6):1589-96. PubMed ID: 16287259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemostatic complications in leukemic patients.
    Goodnight SH
    Geriatrics; 1978 Mar; 33(3):53-7. PubMed ID: 564314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat Model.
    Taguchi K; Hashimoto M; Ogaki S; Watanabe H; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
    J Pharm Sci; 2015 Sep; 104(9):3084-91. PubMed ID: 25755009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits.
    McGill M; Fugman DA; Vittorio N; Darrow C
    J Lab Clin Med; 1987 Feb; 109(2):127-33. PubMed ID: 3805864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis.
    Dyer MR; Hickman D; Luc N; Haldeman S; Loughran P; Pawlowski C; Sen Gupta A; Neal MD
    J Trauma Acute Care Surg; 2018 Jun; 84(6):917-923. PubMed ID: 29538234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of platelets with Synthocytes, a novel platelet substitute.
    Davies AR; Judge HM; May JA; Glenn JR; Heptinstall S
    Platelets; 2002 Jun; 13(4):197-205. PubMed ID: 12189020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo.
    Okamura Y; Takeoka S; Teramura Y; Maruyama H; Tsuchida E; Handa M; Ikeda Y
    Transfusion; 2005 Jul; 45(7):1221-8. PubMed ID: 15987370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of severe intra-abdominal hemorrhage with an infusible platelet-derived hemostatic agent in a nonhuman primate (rhesus macaque) model.
    Macko AR; Crossland RF; Cap AP; Fryer DM; Mitchell TA; Pusateri AE; Sheppard FR
    J Trauma Acute Care Surg; 2016 Apr; 80(4):617-24. PubMed ID: 26808038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets.
    Chao FC; Kim BK; Houranieh AM; Liang FH; Konrad MW; Swisher SN; Tullis JL
    Transfusion; 1996 Jun; 36(6):536-42. PubMed ID: 8669086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions.
    Lee RH; Kasthuri RS; Bergmeier W
    Curr Opin Hematol; 2020 Nov; 27(6):378-385. PubMed ID: 32868672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrastructural analysis of thrombin-induced interaction between human platelets and liposomes carrying fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute.
    Suzuki H; Okamura Y; Ikeda Y; Takeoka S; Handa M
    Thromb Res; 2011 Dec; 128(6):552-9. PubMed ID: 21840573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Algan Hemostatic Agent on bleeding time in a rat tail hemorrhage model.
    Gedar Totuk ÖM; Güzel ŞE; Ekici H; Kumandaş A; Emre Aydıngöz S; Yılmaz EÇ; Kırdan T; Midi A
    Ulus Travma Acil Cerrahi Derg; 2020 Nov; 26(6):853-858. PubMed ID: 33107963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red cell-derived microparticles (RMP) as haemostatic agent.
    Jy W; Johansen ME; Bidot C; Horstman LL; Ahn YS
    Thromb Haemost; 2013 Oct; 110(4):751-60. PubMed ID: 24030707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired disorders of platelet function.
    Hassan AA; Kroll MH
    Hematology Am Soc Hematol Educ Program; 2005; ():403-8. PubMed ID: 16304411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet disorders in newborn infants: diagnosis and management.
    Blanchette VS; Rand ML
    Semin Perinatol; 1997 Feb; 21(1):53-62. PubMed ID: 9190034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage.
    Fitzpatrick GM; Cliff R; Tandon N
    Transfusion; 2013 Jan; 53 Suppl 1():100S-106S. PubMed ID: 23301961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Filtration of active fractions with hemostasis effect from platycladi cacumen carbonisatum].
    Liu C; Liu J; Zheng CZ; Zhang L; Ding AW; Yu B
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3152-6. PubMed ID: 25509305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological responses to liposome-encapsulated hemoglobin (LEH) are improved by a PAF antagonist.
    Rabinovici R; Rudolph AS; Yue TL; Feuerstein G
    Circ Shock; 1990 Aug; 31(4):431-45. PubMed ID: 2397568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel platelet products, substitutes and alternatives.
    Blajchman MA
    Transfus Clin Biol; 2001 Jun; 8(3):267-71. PubMed ID: 11499975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of blood loss by infusion of human platelets in a rabbit kidney injury model.
    Krishnamurti C; Maglasang P; Rothwell SW
    Transfusion; 1999 Sep; 39(9):967-74. PubMed ID: 10533823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.